Aperture Investors, LLC Vivos Therapeutics, Inc. Transaction History

Aperture Investors, LLC

  • $659 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$2.25 - $4.11 $79,371 - $144,984
-35,276 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$2.71 - $5.9 $7,222 - $15,723
2,665 Added 8.17%
35,276 $143,000
Q2 2021

Aug 16, 2021
BUY
$4.83 - $9.67 $157,511 - $315,348
32,611 New
32,611 $161,000

About Vivos Therapeutics, Inc.

VVOS Quotes by TradingView
  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $78.2M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Aperture Investors, LLC Portfolio

Follow Aperture Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aperture Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aperture Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email